Healthcare provider profile · identity verified

Barbara J Bollinger, MD

Internal Medicine · SAINT CLOUD, MN · NPI 1174512081

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	349	86
Amlodipine Besylate	Amlodipine Besylate	324	88
Losartan Potassium	Losartan Potassium	218	61
Omeprazole	Omeprazole	214	65
Metoprolol Succinate	Metoprolol Succinate	171	47
Pantoprazole Sodium	Pantoprazole Sodium	171	51
Atorvastatin Calcium	Atorvastatin Calcium	163	44
Gabapentin	Gabapentin	138	47
Rosuvastatin Calcium	Rosuvastatin Calcium	138	41
Pravastatin Sodium	Pravastatin Sodium	132	36
Lisinopril	Lisinopril	125	34
Montelukast Sodium	Montelukast Sodium	111	28
Furosemide	Furosemide	101	33
Hydrochlorothiazide	Hydrochlorothiazide	97	28
Potassium Chloride	Potassium Chloride	93	28
Simvastatin	Simvastatin	86	25
Citalopram Hbr	Citalopram Hydrobromide	82	21
Prednisone	Prednisone	80	40
Escitalopram Oxalate	Escitalopram Oxalate	78	21
Trazodone Hcl	Trazodone Hcl	78	27
Sertraline Hcl	Sertraline Hcl	66	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	64	19
Metformin Hcl	Metformin Hcl	64	20
Duloxetine Hcl	Duloxetine Hcl	62	17
Metformin Hcl Er	Metformin Hcl	61	20
Spironolactone	Spironolactone	61	15
Mirtazapine	Mirtazapine	59	18
Tramadol Hcl	Tramadol Hcl	59	19
Pregabalin	Pregabalin	56	17
Synthroid	Levothyroxine Sodium	55	14
Eliquis	Apixaban	54	13
Alprazolam	Alprazolam	53	18
Venlafaxine Hcl Er	Venlafaxine Hcl	49	suppressed
Carvedilol	Carvedilol	48	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	48	suppressed
Hydralazine Hcl	Hydralazine Hcl	47	12
Warfarin Sodium	Warfarin Sodium	46	11
Fluticasone Propionate	Fluticasone Propionate	45	20
Buspirone Hcl	Buspirone Hcl	40	12
Ezetimibe	Ezetimibe	40	13
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Famotidine	Famotidine	38	16
Oxybutynin Chloride Er	Oxybutynin Chloride	37	13
Xarelto	Rivaroxaban	37	12
Ventolin Hfa	Albuterol Sulfate	36	16
Valsartan	Valsartan	35	11
Metoprolol Tartrate	Metoprolol Tartrate	34	13
Pioglitazone Hcl	Pioglitazone Hcl	34	suppressed
Amoxicillin	Amoxicillin	33	24
Atenolol	Atenolol	33	11
Cephalexin	Cephalexin	33	22
Nortriptyline Hcl	Nortriptyline Hcl	33	suppressed
Bupropion Xl	Bupropion Hcl	32	11
Lorazepam	Lorazepam	32	suppressed
Meloxicam	Meloxicam	31	11
Allopurinol	Allopurinol	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Temazepam	Temazepam	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Terazosin Hcl	Terazosin Hcl	27	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Sucralfate	Sucralfate	25	11
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Ibandronate Sodium	Ibandronate Sodium	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	12
Estradiol	Estradiol	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	11
Verapamil Er	Verapamil Hcl	21	suppressed
Glimepiride	Glimepiride	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Glipizide Er	Glipizide	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	14
Ibuprofen	Ibuprofen	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Ozempic	Semaglutide	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Belsomra	Suvorexant	11	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error